INTRODUCTION: Despite successful preservation of low-frequency hearing in patients undergoing cochlear implantation (CI) with shorter electrode lengths, there is still controversy regarding which electrodes maximize hearing preservation (HP). The thin straight electrode array (TSEA) has been suggested as a full cochlear coverage option for HP. However, very little is known regarding its HP potential. METHODS: A retrospective review was performed at two tertiary academic medical centers, reviewing the electronic records for 52 patients (mean, 58.2 yr; range, 11-85 yr) implanted with the Cochlear Nucleus CI422 Slim Straight (Centennial, CO, USA) electrode array, referred to herein as the thin straight electrode array or TSEA. All patients had a preoperative low-frequency pure-tone average (LFPTA) of 85 dB HL or less. Hearing thresholds were measured at initial activation (t1) and 6 months after activation (t2). HP was assessed by evaluating functional HP using a cutoff level of 85 dB HL PTA. RESULTS: At t1, 54% of the subjects had functional hearing; 33% of these subjects had an LFPTA between 71 and 85 dB HL, and 17% had an LFPTA between 56 and 70 dB HL. At t2, 47% of the patients had functional hearing, with 31% having an LFPTA between 71 and 85 dB HL. DISCUSSION: Preliminary research suggests that the TSEA has the potential to preserve functional hearing in 54% of patients at t1. However, 22% (n = 6) of the patients who had functional hearing at t1 (n = 28) lost their hearing between t1 and t2. Further studies are needed to evaluate factors that influence HP with the TSEA electrode and determine the speech perception benefits using electric and acoustic hearing over electric alone.
INTRODUCTION: Despite successful preservation of low-frequency hearing in patients undergoing cochlear implantation (CI) with shorter electrode lengths, there is still controversy regarding which electrodes maximize hearing preservation (HP). The thin straight electrode array (TSEA) has been suggested as a full cochlear coverage option for HP. However, very little is known regarding its HP potential. METHODS: A retrospective review was performed at two tertiary academic medical centers, reviewing the electronic records for 52 patients (mean, 58.2 yr; range, 11-85 yr) implanted with the Cochlear Nucleus CI422 Slim Straight (Centennial, CO, USA) electrode array, referred to herein as the thin straight electrode array or TSEA. All patients had a preoperative low-frequency pure-tone average (LFPTA) of 85 dB HL or less. Hearing thresholds were measured at initial activation (t1) and 6 months after activation (t2). HP was assessed by evaluating functional HP using a cutoff level of 85 dB HL PTA. RESULTS: At t1, 54% of the subjects had functional hearing; 33% of these subjects had an LFPTA between 71 and 85 dB HL, and 17% had an LFPTA between 56 and 70 dB HL. At t2, 47% of the patients had functional hearing, with 31% having an LFPTA between 71 and 85 dB HL. DISCUSSION: Preliminary research suggests that the TSEA has the potential to preserve functional hearing in 54% of patients at t1. However, 22% (n = 6) of the patients who had functional hearing at t1 (n = 28) lost their hearing between t1 and t2. Further studies are needed to evaluate factors that influence HP with the TSEA electrode and determine the speech perception benefits using electric and acoustic hearing over electric alone.
Authors: Henryk Skarzynski; P van de Heyning; S Agrawal; S L Arauz; M Atlas; W Baumgartner; M Caversaccio; M de Bodt; J Gavilan; B Godey; K Green; W Gstoettner; R Hagen; D M Han; M Kameswaran; E Karltorp; M Kompis; V Kuzovkov; L Lassaletta; F Levevre; Y Li; M Manikoth; J Martin; R Mlynski; J Mueller; M O'Driscoll; L Parnes; S Prentiss; S Pulibalathingal; C H Raine; G Rajan; R Rajeswaran; J A Rivas; A Rivas; P H Skarzynski; G Sprinzl; H Staecker; K Stephan; S Usami; Y Yanov; M E Zernotti; K Zimmermann; A Lorens; G Mertens Journal: Acta Otolaryngol Suppl Date: 2013
Authors: Paul Mick; Hosam Amoodi; David Shipp; Lendra Friesen; Sean Symons; Vincent Lin; Julian Nedzelski; Joseph Chen Journal: Otol Neurotol Date: 2014-01 Impact factor: 2.311
Authors: Henryk Skarzynski; Artur Lorens; Monika Matusiak; Marek Porowski; Piotr H Skarzynski; Chris J James Journal: Ear Hear Date: 2014 Mar-Apr Impact factor: 3.570
Authors: Matthew L Carlson; Colin L W Driscoll; René H Gifford; Geoffrey J Service; Nicole M Tombers; Becky J Hughes-Borst; Brian A Neff; Charles W Beatty Journal: Otol Neurotol Date: 2011-08 Impact factor: 2.311
Authors: René H Gifford; Michael F Dorman; Henryk Skarzynski; Artur Lorens; Marek Polak; Colin L W Driscoll; Peter Roland; Craig A Buchman Journal: Ear Hear Date: 2013 Jul-Aug Impact factor: 3.570
Authors: Bruce J Gantz; Marlan R Hansen; Christopher W Turner; Jacob J Oleson; Lina A Reiss; Aaron J Parkinson Journal: Audiol Neurootol Date: 2009-04-22 Impact factor: 1.854
Authors: Thomas Lenarz; Timo Stöver; Andreas Buechner; Anke Lesinski-Schiedat; Jim Patrick; Joerg Pesch Journal: Audiol Neurootol Date: 2009-04-22 Impact factor: 1.854
Authors: Alice Emptoz; Vincent Michel; Andrea Lelli; Omar Akil; Jacques Boutet de Monvel; Ghizlene Lahlou; Anaïs Meyer; Typhaine Dupont; Sylvie Nouaille; Elody Ey; Filipa Franca de Barros; Mathieu Beraneck; Didier Dulon; Jean-Pierre Hardelin; Lawrence Lustig; Paul Avan; Christine Petit; Saaid Safieddine Journal: Proc Natl Acad Sci U S A Date: 2017-08-23 Impact factor: 11.205
Authors: Rachel A Scheperle; Viral D Tejani; Julia K Omtvedt; Carolyn J Brown; Paul J Abbas; Marlan R Hansen; Bruce J Gantz; Jacob J Oleson; Marie V Ozanne Journal: Hear Res Date: 2017-04-12 Impact factor: 3.208
Authors: Alicia M Quesnel; Hideko Heidi Nakajima; John J Rosowski; Marlan R Hansen; Bruce J Gantz; Joseph B Nadol Journal: Hear Res Date: 2015-09-01 Impact factor: 3.208